Watchlist Price Alert

Matinas BioPharma Inc. (MTNB)

AMEX: MTNB · Real-Time Price · USD

0.92

-0.01 (-1.22%)

At close: Jun 17, 2025, 3:59 PM

0.88

-4.33%

After-hours: Jun 17, 2025, 06:34 PM EDT

Matinas BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	7.28M	4.79M	6.83M	21.03M	12.43M	22.17M	12.45M	7.31M	4.11M
Short-Term Investments	n/a	8.97M	21.93M	28.59M	46.25M	5.61M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	200K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	200K	200K	-34.05M	200K	200K	336K	460.89K	535.86K	540.99K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	741K	50K	5.77M	50K	136K	250K	100K	155.43K	155.61K
Total Current Assets	8.03M	15.54M	34.53M	50.99M	61.55M	29.92M	13.09M	7.96M	4.57M
Property-Plant & Equipment	2.16M	5.01M	5.73M	5.78M	4.86M	5.63M	2.04M	1.57M	356K
Goodwill & Intangibles	2.26M	4.35M	4.35M	4.35M	4.35M	4.35M	4.35M	4.35M	4.35M
Total Long-Term Assets	4.62M	9.56M	10.29M	10.33M	9.41M	10.32M	6.86M	6.46M	5.25M
Total Assets	12.64M	25.1M	44.82M	61.33M	70.97M	40.24M	19.94M	14.42M	9.82M
Account Payables	95K	514K	618K	937K	349.94K	679.31K	295.65K	582.87K	475.6K
Deferred Revenue	n/a	n/a	721K	932K	643K	100K	-83.25K	29.94K	n/a
Short-Term Debt	766K	n/a	569K	n/a	n/a	n/a	199.84K	170.24K	118.05K
Other Current Liabilities	292K	271K	825K	1.51M	1.7M	862K	1.63M	n/a	11.48K
Total Current Liabilities	2.67M	2.62M	4.29M	4.35M	3.57M	3.1M	2.84M	2.22M	1.44M
Long-Term Debt	n/a	n/a	n/a	4.14B	n/a	3.75B	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	-4.14B	n/a	-3.75B	512.7K	601.14K	n/a
Total Long-Term Liabilities	2.38M	3.24M	3.9M	4.48M	3.67M	4.09M	961.63K	1.52M	1.22M
Total Liabilities	5.05M	5.86M	8.18M	8.83M	7.24M	7.19M	3.8M	3.74M	2.67M
Total Debt	2.89M	3.56M	4.12M	4.7M	3.75M	4.23M	390.74K	264.89K	144.43K
Common Stock	1K	22K	22K	21.63K	20.01K	16K	11.33K	9.34K	5.82K
Retained Earnings	-199.82M	-175.57M	-152.63M	-131.63M	-107.51M	-84.38M	-65.94M	-51.27M	-35.18M
Comprehensive Income	n/a	-221K	-824K	-145.5K	228.17K	-1K	-439K	-0.00	n/a
Shareholders Equity	7.59M	19.25M	36.64M	52.49M	63.73M	33.05M	16.14M	10.68M	7.15M
Total Investments	n/a	8.97M	21.93M	28.59M	46.25M	5.61M	n/a	n/a	n/a